Shree Signify Exim Private Limited

Brand Names: Palnat, Ibrance (widely known brand based on composition)

Composition: Palbociclib 125 mg

Strength: 125 mg

Manufacturer: Natco Pharma Ltd.

Packaging: Typically available in blister packs containing 21 capsules

Treatment: Breast cancer (hormone receptor-positive, HER2-negative)

Product Description:
Palnat 125 Capsule contains Palbociclib, a targeted cancer therapy known as a cyclin-dependent kinase (CDK) 4/6 inhibitor. It is used in combination with hormonal therapies to treat hormone receptor-positive, HER2-negative breast cancer. Palbociclib works by inhibiting the activity of CDK4 and CDK6, which are enzymes that promote cell division. By blocking these enzymes, Palbociclib slows the growth and spread of cancer cells.

Common indications for Palnat 125 Capsule include:

• Breast Cancer: Used in combination with an aromatase inhibitor as the first-line treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. It is also used with fulvestrant in patients whose disease has progressed after endocrine therapy.

Dosage and Administration:

• For Adults: The recommended dose is 125 mg taken orally once daily for 21 consecutive days, followed by 7 days off treatment, making up a 28-day cycle.
• Administration: The capsule should be swallowed whole with water, preferably with food. It should not be chewed, crushed, or opened.

Common side effects of Palnat 125 Capsule may include:

• Neutropenia (low white blood cell count)
• Fatigue
• Nausea
• Diarrhea
• Infections
• Stomatitis (inflammation of the mouth)
• Thrombocytopenia (low platelet count)

Patients are advised to undergo regular blood tests to monitor blood cell counts during treatment, as well as to report any signs of infection or unusual symptoms to their healthcare provider immediately.

Packaging:
Palnat 125 Capsule is typically packaged in blister packs containing 21 capsules, which corresponds to one cycle of treatment.

Palnat 125 Capsule is an important medication in the treatment of advanced breast cancer, offering a targeted approach that, when used in combination with hormonal therapies, can help control the disease and improve survival outcomes. Adherence to the prescribed regimen and regular monitoring are essential to maximize the benefits of this therapy while managing potential side effects.

Brand Names: Lenalid, Revlimid (widely known brand based on composition)

Composition: Lenalidomide 15 mg

Strength: 15 mg

Manufacturer: Natco Pharma Ltd.

Packaging: Typically available in blister packs containing 10 capsules

Treatment: Multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma

Product Description:
Lenalid 15 Capsule contains Lenalidomide, an immunomodulatory agent that is primarily used in the treatment of certain types of cancers, including multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. Lenalidomide works by affecting the immune system to inhibit the growth of cancer cells, promote the destruction of abnormal cells, and reduce the formation of blood vessels that supply tumors.

Common indications for Lenalid 15 Capsule include:

• Multiple Myeloma: Used in combination with other medications to treat multiple myeloma, particularly in patients who have received at least one prior therapy.
• Myelodysplastic Syndromes (MDS): Used to treat certain types of MDS, especially in patients with a specific chromosomal abnormality.
• Mantle Cell Lymphoma: Used in patients whose disease has relapsed or progressed after two prior therapies, including bortezomib.

Dosage and Administration:

• For Adults: The dosage of Lenalid 15 Capsule varies depending on the condition being treated. The exact dosage regimen should be determined by a healthcare provider based on individual patient factors and response to treatment.
• Administration: The capsule should be swallowed whole with water, with or without food. It is important to follow the prescribed schedule and not to break, chew, or open the capsules.

Common side effects of Lenalid 15 Capsule may include:

• Fatigue
• Anemia
• Neutropenia (low white blood cell count)
• Thrombocytopenia (low platelet count)
• Diarrhea
• Rash

Due to the risk of serious side effects, including birth defects, Lenalidomide is subject to special safety monitoring and prescribing programs. Patients should discuss all potential risks and benefits with their healthcare provider.

Packaging:
Lenalid 15 Capsule is typically packaged in blister packs containing 10 capsules, providing a convenient form for daily or cyclical use as prescribed by a healthcare provider.

Lenalid 15 Capsule is a critical medication in the management of certain hematological cancers, offering a targeted approach to treatment that leverages the body's immune system to fight disease. Its use in conditions like multiple myeloma and MDS has significantly improved outcomes for many patients, though it requires careful monitoring and adherence to prescribed safety protocols.

Pivikto 150mg Tablet should be taken with food, but try to take it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. Take it exactly as advised by the doctor. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Some common side effects of this medicine include fatigue, decreased appetite, rash, vomiting, and diarrhea. It may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby increasing the susceptibility to infections. It is better to inform your doctor if you notice symptoms of infection like fever, chills, weakness, bleeding or bruising, and nose bleeding. It might also cause dizziness; so avoid driving or attention-seeking activities if you experience dizziness.

Product Description:
Tretinoin CA Atra 10mg Softgel Capsules contain Tretinoin, a derivative of vitamin A, also known as all-trans retinoic acid (ATRA). This medication is used primarily in the treatment of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia. Tretinoin works by promoting the differentiation of immature blood cells into normal cells, helping to restore normal blood cell production.

In addition to its use in treating APL, Tretinoin is also prescribed for the management of severe acne that has not responded to other treatments. It works by promoting skin cell turnover, reducing the formation of acne and unclogging pores.

Tretinoin softgel capsules are typically part of a combination therapy, particularly in APL treatment, and they are often used alongside other chemotherapy agents. Regular monitoring by a healthcare provider is essential during treatment, and it may take some time to observe the full therapeutic effects

Product Name: Thalix 100 Capsule

Brand Names: Thalix, Thalidomide Celgene, Thalidobid

Composition: Thalidomide (100mg)

Manufacturer/Marketer: Fresenius Kabi India Pvt Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Multiple myeloma, erythema nodosum leprosum (ENL), and other inflammatory conditions

Product Description:
Thalix 100 Capsule contains Thalidomide, an immunomodulatory agent used primarily for the treatment of multiple myeloma and erythema nodosum leprosum (ENL). It works by modulating the immune system and has anti-inflammatory effects. Caution is required due to its teratogenic effects, and its use is strictly regulated in women of childbearing age

• Product Name: Pemnat 500mg Injection

  Brand Name: Alimta, Pemnat, Pemecad

  Composition: Pemetrexed (500mg)

  Manufacturer/Marketer: Natco Pharma Ltd

  Packaging: Vial of 500mg injection

  Treatment: Lung cancer, mesothelioma

  Product Description: Pemnat 500mg Injection contains Pemetrexed, a chemotherapy medication used to treat certain types of lung cancer and mesothelioma. It works by interfering with the growth of cancer cells, slowing their spread and ultimately destroying them

• Kidney cancer

Cycloxan 500 mg Injection:

• Brand Names: Cycloxan, Endoxan, Cytoxan
• Composition: Cyclophosphamide 500 mg
• Strength: 500 mg
• Manufacturer/Marketer: Biochem Pharmaceutical Industries Ltd
• Packaging: Injection vial
• Treatment: Used for treating cancer, including lymphoma, leukemia, breast cancer, and ovarian cancer. It is also used in autoimmune disorders like severe rheumatoid arthritis and lupus.

Product Description:
Cycloxan 500 mg Injection contains Cyclophosphamide, an anti-cancer (antineoplastic) medication from the alkylating agent class. It works by slowing or stopping the growth of cancer cells. It's administered via injection under medical supervision, typically in chemotherapy regimens. Cyclophosphamide is also used to suppress the immune system in cases of severe autoimmune conditions.

Commonly available under brand names such as Cycloxan, Endoxan, and Cytoxan, this drug is widely used for treating various types of cancer and certain autoimmune diseases

Brand Names: Tykerb

Composition: Lapatinib

Strength: 250 mg

Manufacturer: GlaxoSmithKline (GSK)

Packaging: Blister pack of 30 tablets

Treatment: HER2-Positive Breast Cancer

Product Description:
Tykerb 250 mg Tablet contains Lapatinib, a tyrosine kinase inhibitor used in the treatment of HER2-positive breast cancer. Lapatinib targets specific receptors involved in cancer cell growth, particularly the human epidermal growth factor receptor 2 (HER2) and epidermal growth factor receptor (EGFR). By inhibiting these receptors, Tykerb helps to slow down or stop the growth of cancer cells.

Common indications for Tykerb Tablet include:

• HER2-Positive Breast Cancer: Tykerb is used in combination with other medications, such as capecitabine or letrozole, to treat HER2-positive metastatic breast cancer that has not responded to previous therapies.

Dosage and Administration: The usual dosage of Tykerb is determined by the healthcare provider based on the patient’s specific condition and response to treatment. It is important to follow the prescribed dosage and administration schedule as directed.

Common side effects of Tykerb may include:

• Diarrhea
• Nausea
• Vomiting
• Fatigue
• Rash
• Liver enzyme abnormalities

More serious side effects can include potential cardiac issues, severe liver problems, and severe allergic reactions. Regular monitoring and follow-ups with the healthcare provider are essential to manage these potential risks and adjust the treatment as needed.

Packaging: Tykerb 250 mg is typically available in blister packs containing 30 tablets. This packaging helps ensure the medication's stability and allows for convenient dosing.

Tykerb is manufactured by GlaxoSmithKline (GSK), a leading pharmaceutical company known for its high-quality products. It offers a targeted therapy option for managing HER2-positive breast cancer, providing a critical tool for patients with this type of cancer. Regular consultations with healthcare professionals are important for monitoring the effectiveness of the therapy and managing any potential side effects.

Product Description: Silofast 8mg Capsules contain Silodosin 8mg, a selective alpha-1 adrenergic receptor antagonist that is primarily used to treat symptoms of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland in men. By relaxing the muscles in the prostate and bladder neck, Silodosin helps relieve symptoms such as difficulty in urination, a weak urine stream, and frequent or urgent urination, allowing smoother urine flow.

Silofast is highly effective in improving urinary symptoms and quality of life for men with BPH. It specifically targets the alpha-1A receptors in the prostate, minimizing the effect on blood pressure compared to other alpha-blockers. This makes it suitable for older patients or those with comorbidities.

Common side effects include dizziness, retrograde ejaculation (where semen enters the bladder instead of exiting through the penis), and a runny or stuffy nose. It is advised to take the capsule with food to reduce the risk of side effects, and patients should avoid operating heavy machinery or driving until they know how the medication affects them.

Silofast 8mg should be used under medical supervision, and patients are encouraged to consult their healthcare provider if they experience any severe side effects or if their symptoms do not improve. Regular follow-ups may be necessary to monitor the progression of BPH and the effectiveness of the treatment.

• Blood cancer (Chronic myeloid leukaemia)

• Abdominal pain
• Nausea
• Vomiting
• Diarrhea
• Headache
• Cough
• Low blood platelets
• Anemia (low number of red blood cells)
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Respiratory tract infection
• Decreased white blood cell count (neutrophils)
• Breathlessness
• Increased liver enzymes

Rexigo 120mg tablet contains an active component called Relugolix, which belongs to a class of medicine called gonadotropin-releasing hormone (GnRH) receptor antagonists. It is used to treat adults with advanced hormone-sensitive prostate cancer. 

Product Name: Temoside 100 Capsule

Brand Name: Temoside, Temodal, Temonat

Composition: Temozolomide (100mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: Strip of 5 capsules

Treatment: Brain tumors (glioblastoma multiforme, anaplastic astrocytoma)

Product Description: Temoside 100 Capsule contains Temozolomide, an oral chemotherapy drug used in the treatment of certain types of brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. It works by slowing or stopping the growth of cancer cells

Product Name: Posid 50mg Capsule

Brand Name: Posid, VePesid, Etopophos

Composition: Etoposide (50mg)

Manufacturer/Marketer: CADILA Pharmaceuticals Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Cancer, including lung cancer and testicular cancer

Product Description: Posid 50mg Capsule contains Etoposide, a chemotherapy medication used to treat various types of cancer, including lung cancer and testicular cancer. It works by interfering with the DNA replication process in cancer cells, preventing their growth and multiplication

Product Name: Aprecap 125/80 Capsule

Brand Name: Aprecap, Emend, Aprepit

Composition: Aprepitant (125mg) + Aprepitant (80mg)

Manufacturer/Marketer: Glenmark Pharmaceuticals Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Prevention of nausea and vomiting caused by chemotherapy

Product Description: Aprecap 125/80 Capsule contains Aprepitant, a medication used to prevent nausea and vomiting associated with cancer chemotherapy. It works by blocking neurokinin-1 (NK1) receptors in the brain, which helps control the vomiting reflex triggered by chemotherapy treatments

Product Name: Cazanat 40 Tablet

Brand Name: Cazanat, Cabometyx, Cabozanib

Composition: Cabozantinib (40mg)

Manufacturer/Marketer: Natco Pharma Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Kidney cancer, liver cancer, thyroid cancer

Product Description: Cazanat 40 Tablet contains Cabozantinib, a targeted therapy medication used to treat advanced kidney, liver, and thyroid cancers. It works by inhibiting the growth of cancer cells by blocking specific proteins involved in tumor growth and angiogenesis, thereby reducing the spread of the disease

Product Name: Biovorin 15mg Tablet

Brand Name: Biovorin, Leucovorin, Folinic

Composition: Calcium Leucovorin / Calcium Folinate (15mg)

Manufacturer/Marketer: Zydus Cadila

Packaging: To be provided (specify packaging details if available)

Treatment: Methotrexate toxicity, megaloblastic anemia, colorectal cancer (as adjuvant therapy)

Product Description: Biovorin 15mg Tablet contains Calcium Leucovorin (Calcium Folinate), a medication used to reduce the harmful effects of methotrexate in cancer therapy, treat megaloblastic anemia due to folic acid deficiency, and enhance the efficacy of fluorouracil in colorectal cancer treatment. It works by replenishing folate levels and protecting healthy cells from damage

Product Name: Cytomid 250 Tablet

Brand Name: Cytomid, Flutax, Flutacan

Composition: Flutamide (250mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Prostate cancer

Product Description: Cytomid 250 Tablet contains Flutamide, an anti-androgen medication used in the treatment of prostate cancer. It works by blocking the action of male hormones (androgens) that promote the growth of cancer cells in the prostate gland, thereby slowing disease progression

Product Name: Calutide 50 Tablet

Brand Name: Calutide, Casodex, Bicalutide

Composition: Bicalutamide (50mg)

Manufacturer/Marketer: Cipla Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Prostate cancer

Product Description: Calutide 50 Tablet contains Bicalutamide, an anti-androgen medication used in the treatment of prostate cancer. It works by blocking the action of male hormones (androgens) that promote the growth of cancer cells, slowing the progression of the disease

Product Name: Pazinib 400mg Tablet

Brand Name: Pazinib, Votrient, Pazocip

Composition: Pazopanib (400mg)

Manufacturer/Marketer: Hetero Healthcare Limited

Packaging: To be provided (specify packaging details if available)

Treatment: Renal cell carcinoma (kidney cancer), advanced soft tissue sarcoma

Product Description: Pazinib 400mg Tablet contains Pazopanib, a tyrosine kinase inhibitor used in the treatment of advanced kidney cancer (renal cell carcinoma) and certain types of soft tissue sarcoma. It works by inhibiting the growth of cancer cells by blocking specific enzymes required for tumor growth and blood supply

Product Name: Midostar 25mg Softgel Capsule

Brand Name: Midostar, Rydapt, Midostaurin

Composition: Midostaurin (25mg)

Manufacturer/Marketer: Zydus Healthcare Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Acute myeloid leukemia (AML), systemic mastocytosis

Product Description: Midostar 25mg Softgel Capsule contains Midostaurin, a kinase inhibitor used in the treatment of acute myeloid leukemia (AML) and systemic mastocytosis. It works by targeting specific proteins involved in cancer cell growth, helping to slow or stop the progression of the disease

Product Name: Honvan Tablet
Brand Name: Honvan, 
Composition: Fosfestrol (120mg)
Manufacturer/Marketer: Zydus Cadila
Packaging: To be provided (specify packaging details if available)
Treatment: Advanced prostate cancer

Product Description:
Honvan Tablet contains Fosfestrol, an estrogen analogue used primarily in the treatment of advanced prostate cancer. It works by inhibiting the production of male hormones that promote cancer growth, thus reducing symptoms and slowing disease progression

Product Name: Tucanat 150 Tablet

Brand Name: Tucanat, Tukysa, Tuksan

Composition: Tucatinib (150mg)

Manufacturer/Marketer: Natco Pharma Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: HER2-positive breast cancer (advanced or metastatic)

Product Description: Tucanat 150 Tablet contains Tucatinib, a tyrosine kinase inhibitor used in the treatment of advanced or metastatic HER2-positive breast cancer. Often used in combination with other therapies like trastuzumab and capecitabine, it works by selectively inhibiting the HER2 signaling pathway, slowing cancer cell growth and spread

Gefitinib Tablet is an anti-cancer medicine. It contains 30 Tablets per bottle. Formulated under the supervision of medical experts, Available in temper-proof packaging, our products are thoroughly tested by medical experts to ensure zero impurity.Gefitinib tablets are indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of both platinum-based and chemotherapies.

Features:

• Effective
• Accurately composed
• Hygienically prepared and packed

Dosage:

• Available as 250mg tablets

Overdose:

• Symptoms like diarrhea and rash

Precautions & Warnings:

• Should not be taken without consulting the doctor if the patient ever had pulmonary fibrosis (scarring of the lungs), or liver or kidney disease
• Not recommended if the patient is allergic to the medicine or any of its constituents
• Kindly notify the doctor immediately, if allergic reactions (difficulty breathing, closing of the throat, swelling of the lips, tongue, or face; or hives), lung problems, liver problems, eye problems, severe nausea, vomiting, loss of appetite, or diarrhea during treatment are noticed
• Doctor consultation recommended for pregnant women or for those who are breast feeding their child

Brand Names: Opdyta, Opdivo (widely known brand based on composition)

Composition: Nivolumab 40 mg

Strength: 40 mg/4 mL

Manufacturer: Bristol-Myers Squibb

Packaging: Typically available in a single-dose vial containing 4 mL of solution

Treatment: Various types of cancer including melanoma, non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), classical Hodgkin lymphoma, head and neck cancer, urothelial carcinoma, and colorectal cancer.

Product Description:
Opdyta 40mg Injection contains Nivolumab, an immune checkpoint inhibitor that targets the programmed death-1 (PD-1) pathway, a mechanism used by cancer cells to avoid being attacked by the immune system. By inhibiting PD-1, Nivolumab reactivates T-cells to recognize and destroy cancer cells. This immunotherapy is used to treat several types of advanced cancers, often in cases where other treatments have failed or are unsuitable.

Common indications for Opdyta 40mg Injection include:

• Melanoma: Used in the treatment of unresectable or metastatic melanoma.
• Non-Small Cell Lung Cancer (NSCLC): Approved for the treatment of metastatic NSCLC after platinum-based chemotherapy.
• Renal Cell Carcinoma (RCC): Used in the treatment of advanced RCC after prior anti-angiogenic therapy.
• Classical Hodgkin Lymphoma: For patients whose disease has relapsed or progressed after autologous hematopoietic stem cell transplantation and brentuximab vedotin.
• Head and Neck Cancer: Used in recurrent or metastatic squamous cell carcinoma of the head and neck.
• Urothelial Carcinoma: For patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy.
• Colorectal Cancer: Used for the treatment of metastatic colorectal cancer with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors.

Dosage and Administration:

• For Adults: The dosage varies based on the type of cancer being treated and the patient's body weight, typically administered as an intravenous infusion over 30 minutes every 2 or 4 weeks.
• Administration: Opdyta is administered as an intravenous infusion by a healthcare professional in a clinical setting. Dosage and frequency depend on the specific condition being treated and patient response.

Common side effects of Opdyta 40mg Injection may include:

• Fatigue
• Nausea
• Rash
• Diarrhea
• Anemia
• Hepatitis
• Colitis

Patients are closely monitored during treatment for potential immune-related adverse effects, which can affect various organs and require immediate medical attention.

Packaging:
Opdyta 40mg Injection is typically packaged in a single-use vial containing 4 mL of solution for infusion, designed for single-dose use.

Opdyta 40mg Injection represents a significant advancement in cancer immunotherapy, offering new treatment options for patients with various types of advanced cancers. By harnessing the body's immune system to fight cancer, Opdyta has become a vital component in the management of cancers that are otherwise difficult to treat. Close monitoring and adherence to the prescribed infusion schedule are crucial for maximizing the benefits of this therapy while managing potential side effects.

Pomalid 1/2/4 mg Capsule:

• Brand Names: Pomalid, Pomalyst, Pomalong
• Composition: Pomalidomide (1mg, 2mg, or 4mg)
• Manufacturer/Marketer: Natco Pharma Ltd
• Packaging: Box of 21 capsules
• Treatment: Used for the treatment of multiple myeloma (a type of blood cancer) and other conditions related to cancer.

Product Description:
Pomalid contains Pomalidomide, which is an immunomodulatory agent that helps slow down the growth of cancer cells and boosts the immune system to attack cancer. It is commonly used in patients with multiple myeloma who have not responded well to other treatments.

Popular alternatives to Pomalid include Pomalyst and Pomalong

Ondem 4 Tablet:

• Brand Names: Ondem, Emeset, Zofran
• Composition: Ondansetron 4 mg
• Strength: 4 mg
• Manufacturer/Marketer: Alkem Laboratories Ltd
• Packaging: Blister pack of tablets
• Treatment: Used for preventing nausea and vomiting caused by chemotherapy, radiation therapy, or surgery.

Product Description:
Ondem 4 Tablet contains Ondansetron 4 mg, a selective serotonin 5-HT3 receptor antagonist. It is primarily used to prevent and treat nausea and vomiting associated with cancer treatments like chemotherapy and radiotherapy, as well as post-operative nausea. By blocking the actions of chemicals that can trigger nausea, Ondem helps ensure patient comfort during medical procedures.

Popular brands like Ondem, Emeset, and Zofran are commonly prescribed for managing nausea and vomiting across various clinical settings. Manufactured by Alkem Laboratories Ltd, Ondem 4 Tablet provides reliable support in preventing nausea and improving patient outcomes

Brand Names: Tagrisso (widely known brand based on composition)

Composition: Osimertinib

Strength: 80 mg

Manufacturer: AstraZeneca

Packaging: Typically available in a pack of 30 tablets

Treatment: Non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations

Product Description:
Tagrisso 80mg Tablet contains Osimertinib, a targeted cancer therapy used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR). Osimertinib is an EGFR tyrosine kinase inhibitor (TKI) that works by blocking the activity of the mutated EGFR, which drives the growth and spread of cancer cells. It is particularly effective against NSCLC that has developed resistance to other EGFR inhibitors.

Common indications for Tagrisso 80mg Tablet include:

• Cancer Treatment: Used in the management of non-small cell lung cancer (NSCLC) with specific EGFR mutations.

Dosage and Administration:

• For Adults: The typical dose is one 80 mg tablet taken orally once daily. The exact dosage and duration of treatment are determined by the oncologist based on the patient's condition and response to therapy.
• Administration: Tagrisso should be taken with or without food, and at the same time each day.

Common side effects of Tagrisso 80mg Tablet may include:

• Diarrhea
• Rash
• Dry skin
• Stomatitis (inflammation of the mouth)
• Nail changes

Serious side effects can include interstitial lung disease, QT prolongation (a type of heart rhythm problem), and low blood cell counts. Regular monitoring of lung function, heart function, and blood tests is essential during treatment.

Packaging:
Tagrisso 80mg Tablet is typically packaged in a box containing 30 tablets, with each tablet individually sealed to ensure proper dosage and patient safety.

Tagrisso 80mg Tablet is a vital medication in the treatment of non-small cell lung cancer (NSCLC) with specific EGFR mutations. It offers a targeted approach that can significantly improve outcomes for patients with this type of cancer. However, due to its potential for serious side effects, it should be used under the guidance and supervision of an experienced oncologist. Regular monitoring of patient health and response to therapy is crucial during treatment with Osimertinib.

• Breast cancer
• Cancer of colon and rectum

• In Breast cancerCapetero 500mg Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Capetero 500mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.In Cancer of colon and rectumCancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Capetero 500mg Tablet treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

Nubeqa 300mg tablet consists of the active ingredient Darolutamide. It is an androgen receptor inhibitor used for treating adult men with non-metastatic castration-resistant prostate cancer. It is also approved to treat hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications. Prostate cancer occurs when the prostate cells start multiplying and dividing abnormally. Do not take this medicine if you are allergic to darolutamide or any other ingredient in it.    

Effective contraception is to be taken while using Nubeqa 300mg Tablet, and it must be continued till one week after the last dose with this medication to prevent pregnancy. Before starting treatment with this medication, inform your doctor if you have any liver problems, kidney problems, heart conditions, or allergic conditions.  

Nubeqa 300mg tablet may cause infertility in men, hence discuss your fertility concerns with your doctor before beginning treatment with this medication. Inform your doctor if you are lactose intolerant before starting treatment with this medication, as it contains lactose. Fatigue, rash, and pain in muscle, bone, arms, and legs are common side effects of this medication. 

• Non-metastatic, castration-resistant prostate cancer (prostate cancer that hasn’t spread to other body parts and does not respond to medicinal or surgical treatment)
• Hormone-sensitive metastatic prostate cancer in combination with other anti-cancer medications.

Therapeutic Effects of Nubeqa 300mg Tablet

Nubeqa 300mg tablet works by inhibiting the activity of androgens (testosterone) which are male sex hormones. Inhibition of these hormones stops the growth, division and multiplication of cancer cells. 

Inform your doctor about any prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products that you are taking or have taken before the treatment. Certain medicines may interact with Nubeqa 300mg tablet and can cause undesirable side effects. 

• Keep Darolutamide out of sight and reach of children.
• This medication is to be stored at or below 30 °C.
• If you missed your regular dose, take it as soon as you remember. If it is 2 hours or less before your next dose, do not take the missed dose.  Inform your physician about the missed dose. Do not take 2 doses at the same time.

Nubeqa 300mg tablet is to be taken exactly as prescribed by your healthcare provider. Swallow this medication whole with food and water. The frequency of administration will be decided by your doctor based on the severity. 

Brand Names: Bracanat, Lynparza (widely known brand based on composition)

Composition: Olaparib 150 mg

Strength: 150 mg

Manufacturer: Natco Pharma Ltd.

Packaging: Typically available in blister packs containing 14 tablets

Treatment: Ovarian cancer, breast cancer, pancreatic cancer, prostate cancer

Product Description:
Bracanat 150mg Tablet contains Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor used in the treatment of various cancers, particularly those associated with BRCA gene mutations. Olaparib works by blocking the PARP enzyme, which helps repair damaged DNA in cells. By inhibiting this enzyme, Olaparib prevents cancer cells from repairing themselves, leading to their death.

Common indications for Bracanat 150mg Tablet include:

• Ovarian Cancer: Used in the maintenance treatment of adult patients with advanced ovarian cancer who have responded to first-line platinum-based chemotherapy.
• Breast Cancer: Used in the treatment of HER2-negative breast cancer with BRCA1/2 mutations.
• Pancreatic Cancer: Used in the maintenance treatment of BRCA-mutated metastatic pancreatic cancer.
• Prostate Cancer: Used in the treatment of metastatic castration-resistant prostate cancer with BRCA1/2 mutations.

Dosage and Administration:

• For Adults: The usual recommended dose is 300 mg (two 150 mg tablets) taken orally twice daily, for a total daily dose of 600 mg.
• Administration: The tablet should be swallowed whole with water, taken at approximately the same times each day, with or without food. It should not be crushed, chewed, or split.

Common side effects of Bracanat 150mg Tablet may include:

• Nausea
• Fatigue
• Anemia
• Vomiting
• Diarrhea
• Loss of appetite

Regular blood tests and monitoring are essential during treatment to manage potential side effects and adjust the dosage as needed.

Packaging:
Bracanat 150mg Tablet is typically packaged in blister packs containing 14 tablets, designed for a one-week course of treatment when taken as prescribed.

Bracanat 150mg Tablet is a significant advancement in cancer treatment, offering targeted therapy for patients with specific genetic mutations. It plays a crucial role in extending survival and improving the quality of life for patients with certain types of advanced cancers, particularly those associated with BRCA mutations. Regular monitoring and adherence to the prescribed regimen are vital to achieving the best possible outcomes.

• Indication:
• Bandrone is used for the treatment and prevention of osteoporosis in postmenopausal women. Bandrone agents affecting on bone metabolism